Your basket is currently empty!
EU follows US & approves Keytruda for 1st line RCC
Merck & Co/MSD’s PD-1 inhibitor Keytruda received FDA approval earlier in 2019 for use alongside Pfizer’s ...
News Archive
Day: 13 September 2019
Our work depends on donations from generous people so that we can support those affected by kidney cancer.
Would you like to support our work through a donation?
